Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

M3, Inc. (MTHRF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
29.290.00 (0.00%)
At close: 03:35PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close29.29
Open29.29
BidN/A x N/A
AskN/A x N/A
Day's Range29.29 - 29.29
52 Week Range28.23 - 73.19
Volume7,935
Avg. Volume1,045
Market Cap19.884B
Beta (5Y Monthly)1.00
PE Ratio (TTM)40.12
EPS (TTM)0.73
Earnings DateN/A
Forward Dividend & Yield0.12 (0.41%)
Ex-Dividend DateMar 30, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MTHRF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • M3 INC
    Analyst Report: MERCK Kommanditgesellschaft auf AktienMerck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (46% of 2021 sales) provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (36%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
  • PR Newswire

    M3-WAKE RESEARCH ACQUIRES MULTI-SPECIALTY RESEARCH ASSOCIATES OF LAKE CITY, FLORIDA

    M3 Wake Research, one of North America's largest leading fully integrated network of clinical research sites, announces the acquisition of Multi-specialty Research Associates (MSRA) in Lake City, Florida. This acquisition expands Wake Research's coast-to-coast coverage of clinical research populations in the United States and encompasses communities at 23 locations across eight states.

Advertisement
Advertisement